Our annual Keynote Lecture showcases some of the latest advancements being made in stroke research.
This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester. Professor Rothwell is one of the UK’s leading neuroscientists whose research focuses on inflammation in brain disease, especially stroke.
This programme of work had been created by experts in stroke and vascular dementia working with people affected by both conditions. This research programme aims to find out who will develop memory and thinking problems after stroke, why this happens, and how we can treat these issues.
Exploring the causes of ‘jargon speech’ through electrophysiology and using it to help stroke survivors that deal with it.
Aphasia is a long-term condition and many people will continue to need support for several years after its onset. However, with the right tools and support, even someone with severe aphasia can continue to communicate effectively.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Thousands of lives a year could be changed thanks to a pilot research study by Imperial College which involves injecting a patient's stem cells into their brain.
Funded by the Wellcome Trust, researchers at Newcastle University have shown that, in monkeys, it is possible to restore hand and arm movement lost through brain damage.
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association-funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study).
Can a drug commonly used for gout improve recovery and prevention of further stroke for stroke survivors?